Thiopental-Dexmedetomidine as Adjuvant Anesthesia for Craniotomy Tumor Removal: A Case Report

Dewi Yulianti Bisri, Dian Nuryanda, Muhammad Rezanda Alifahna, Tatang Bisri


Brain tumor surgery requires special anesthesia to get a slack brain and perform perioperative brain protection. The selected anesthetic drugs and adjuvants have the ability of anesthesia sparring effect and have a brain protective effect. Not many have done the combination of thiopental adjuvant with dexmedetomidine. The purpose of this case report is to see the effect of the combination of thiopental with dexmedetomidine as an adjuvant anesthesia on hemodynamics and slack brain and successful removal of brain tumors. A woman, 32 years old, with meningiomas had surgery to remove a brain tumor at Santosa Bandung Central Hospital. Preoperative examination showed blood lab results within normal limits, the presence of large meningioma and midline shift. Induction of anesthesia with thiopental 5 mg/kgBW, rocuronium bromide 0.9 mg/kgBW, fentanyl 3 mcg/kg and anesthetic maintenance with sevoflurane below 1.5 MAC, oxygen/air, continuous rocuronium 0.5 mg/kgBW/hour, thiopental and continuous dexmedetomidine. The anesthetic adjuvant used was thiopental 1-3 mg/kg/hour and continuous dexmedetomidine 0.4–0.7 mcg/kg/hour. A slack brain is obtained, and 90% of the tumor could be removed, and transfused during surgery 4 units pack red cells (PRC), crystalloid liquid as much as 2,500 cc, and colloidal fluid as much as 2,000 cc. The length of surgery is 11 hours. Post-surgery was treated in the ICU for 5 days, then moved to the ward for 2 days then the patient could be discharged from the hospital. The use of thiopental and dexmedetomidine continuously can produce slack brain and almost the entire tumor can be removed.


Alpha-2 agonist dexmedetomidine, adjuvant anesthesia, brain tumor, sevoflurane, thiopental

Full Text:



Batra A, Verma R, Bhatia VK, Chandra G, Bhushan S. Dexmedetomidine as an anesthetic adjuvant in intracranial surgery. Anesth Essays Res 2017;11(2):309-13. Doi: 10.4103/0259-1162.194555

Bisri DY, Bisri T. Anestesi Untuk Operasi Tumor Otak: Supratentorial dan Infratentorial. Bandung: Fakultas Kedokteran Universitas Padjadjaran; 2016

Gaudet JG, Schoettker P, Bruder NJ. Supratentorial mass: anesthetic consideration. In: Cottrell JE, Patel PM, Soriano SG, eds. Cottrell and Patel’s Neuroanesthesia, seventh ed, Philadelphia: Elsevier; 2025, 206

Bisri DY, Hallis IK, Saputra TA, Bisri T. Brain relaxation score on craniotomy brain tumor removal with adjuvant thiopental and dexmedetomidine: a case report. J Adv Phar Educ Res 2023;23(3):73-8. Doi:

Bisri DY, Septiani GAP, Limawan MA, Bisri T. Anesthesia management of patients with redo craniotomy: cases of supratentorial recidive tumors. Interdisciplinary Social Studies, May 2023;2(8):2215. Doi:

Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93(2):382–94. Doi: 10.1097/00000542-200008000-00016

Soliman RN, Hassan AR, Rashwan AM, Omar AM. Prospective, randomized study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anaesthesia. Middle East J Anaesthesiol 2011;21:325–34.

Ilhan O, Koruk S, Serin G, Erkutlu I, Oner U. Dexmedetomidine in the supratentorial craniotomy. Eurasian J Med 2010;42:61–5. Doi: 10.5152/eajm.2010.19

Tanskanen PE , Kyttä JV, Randell TT, Aantaa RE. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study. Br J Anaesth. 2006; 97(5):658-65. Doi: 10.1093/bja/ael220

Basar H, Akpinar S, Doganci N, Buyukkocak U, Kaymak C, Sert O, et al. The effects of preanesthetic, single-dose dexmedetomidine on induction, hemodynamic, and cardiovascular parameters. J Clin Anesth 2008;20:431–6. Doi: 10.1016/j.jclinane.2008.04.007

Keniya VM, Ladi S, Nahpadi R. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth. 2011;55:352–7. Doi: 10.4103/0019-5049.84846

Bekker A, Sturaitis M, Bloom M, Moric M, Golfinos J, Parker E, Babu R, Pitti A. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg.2008;107(4):1340-7. Doi: 10.1213/ane.0b013e3181804298

Matsumoto M, Yamashita A. Effects of anesthetic agents and other drugs on cerebral blood flow, metabolism, and intracranial pressure. In: Cottrell JE, Patel PM, Soriano SG, eds. Cottrell and Patel’s Neuroanesthesia, seventh ed, Philadelphia: Elsevier; 2025,

Tasbihguo SR, Barends CRM, Absalom AR. The role of dexmedetomidine in neurosurgery. Best Practice & Research Clinical Anesthesiology 2021;35(2):221-29

Lin N, Vuskits L, Bebawy JF, Gelb A. Perspective on dexmedetomidine use for neurosurgical patient. Journal of Neurosurgical Anesthesiology 2019;31(4):366-77

Peng K, Wu S, Liu H, Ji F. Dexmedetomidine as an anesthetic adjuvant for intracranial procedure: metaanalysis of randomized control trial. Journal of clinical neuroscience 2014;21: 1951–58



  • There are currently no refbacks.



JNI is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License